Abstract
Summary. A patient is described who presented with a combined preleukaemic, lymphoproliferative and plasma cell disorder. These disorders were not related to cytotoxic therapy. The clonal nature of the lymphoid component was demonstrated by lymphocyte surface marker studies and the clonal nature of the plasma cell component by immunoperoxidase studies. Since the involved lymphoid and plasma cells contained different heavy and light chains, they were felt to originate from two separate B cell clones not related to the clone responsible for the preleukaemic component.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 125-133 |
| Number of pages | 9 |
| Journal | British Journal of Haematology |
| Volume | 53 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 1983 |
Fingerprint
ASJC Scopus subject areas
- Hematology
Cite this
Concurrent development of preleukaemic, lymphoproliferative and plasma cell disorders. / Greenberg, Bernard R.; Miller, Claramae; Cardiff, Robert; Mackenzie, Malcolm R.; Walling, Paula.
In: British Journal of Haematology, Vol. 53, No. 1, 01.01.1983, p. 125-133.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Concurrent development of preleukaemic, lymphoproliferative and plasma cell disorders
AU - Greenberg, Bernard R.
AU - Miller, Claramae
AU - Cardiff, Robert
AU - Mackenzie, Malcolm R.
AU - Walling, Paula
PY - 1983/1/1
Y1 - 1983/1/1
N2 - Summary. A patient is described who presented with a combined preleukaemic, lymphoproliferative and plasma cell disorder. These disorders were not related to cytotoxic therapy. The clonal nature of the lymphoid component was demonstrated by lymphocyte surface marker studies and the clonal nature of the plasma cell component by immunoperoxidase studies. Since the involved lymphoid and plasma cells contained different heavy and light chains, they were felt to originate from two separate B cell clones not related to the clone responsible for the preleukaemic component.
AB - Summary. A patient is described who presented with a combined preleukaemic, lymphoproliferative and plasma cell disorder. These disorders were not related to cytotoxic therapy. The clonal nature of the lymphoid component was demonstrated by lymphocyte surface marker studies and the clonal nature of the plasma cell component by immunoperoxidase studies. Since the involved lymphoid and plasma cells contained different heavy and light chains, they were felt to originate from two separate B cell clones not related to the clone responsible for the preleukaemic component.
UR - http://www.scopus.com/inward/record.url?scp=0020665192&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0020665192&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2141.1983.tb01994.x
DO - 10.1111/j.1365-2141.1983.tb01994.x
M3 - Article
C2 - 6216909
AN - SCOPUS:0020665192
VL - 53
SP - 125
EP - 133
JO - British Journal of Haematology
JF - British Journal of Haematology
SN - 0007-1048
IS - 1
ER -